Press Releases and Statements

CHPA today announced that Beth Allgaier has been named Senior Vice President, Business Development and Industry Relations. Allgaier will be responsible for the association’s membership, education, and meetings functions, in addition to serving as chief liaison to the retail community.

CHPA today applauds the U.S. Food and Drug Administration for enforcing existing provisions in the Federal Food, Drug, and Cosmetic Act by sending warning letters to 15 companies illegally marketing cannabidiol products.

At its fall meeting, CHPA leadership approved Amardeep Kahlon, Chief Marketing Officer and Vice President of U.S. Marketing at GSK Consumer Healthcare to serve as the new chair of the CHPA Educational Foundation’s board of directors.

At CHPA’s fall meeting, the Board of Directors elected Barry Reichgott, General Manager, Colgate Oral Pharmaceuticals, Colgate-Palmolive Company, as its newest member. In June, Dan Quail, president, North America, Similasan USA was approved to serve on the board.

Michigan Governor Gretchen Whitmer today signed HB 4412, legislation to combat teen abuse of OTC medicines containing the cough suppressant dextromethorphan (DXM).

Today CHPA submitted a citizen petition to the U.S. Food and Drug Administration urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol in dietary supplements. 

Through several CHPA member company donations, 144 U.S. schools of pharmacy received over 100 different OTC medicines, medical devices, and dietary supplements to educate and prepare future pharmacists.

CHPA supports and encourages continued research and promotes ongoing consumer education to help ensure safe use of OTC medicines.

The Senate HELP Committee made a strong bipartisan move to modernize the regulatory system overseeing most OTC medicines by approving S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act by voice vote.

The Consumer Healthcare Products Association (CHPA) issued the following statement today following the introduction of S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act.

CHPA issued the following statement today following the introduction of S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act, sponsored by Senators Johnny Isakson (R-Ga.) and Bob Casey (D-Pa.).

CHPA President and CEO, Scott Melville, issued the following statement in response to Congressman Greg Walden’s announced retirement.